How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,731 results for

covid-19 and diagnosis

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. NCCP advice for Medical Professionals on the Management of patients with Suspected or Diagnosed Malignant Melanoma or Non-Melanoma Skin Cancer in response to the current novel coronavirus (COVID-19) pandemic

NCCP advice for Medical Professionals on the Management of patients with Suspected or Diagnosed Malignant Melanoma or Non-Melanoma Skin Cancer in response to the current novel coronavirus (COVID-19) pandemic Version: 1 Department: NCCP Skin Cancer Leads Group Last updated: 01/05/2020 Code: SK_COVID19_1 Page 1 of 6 NCCP advice for Medical Professionals on the Management of patients with Suspected or Diagnosed Malignant Melanoma or Non-Melanoma Skin Cancer in response to the current novel (...) coronavirus (COVID-19) pandemic This document relates to patients who do not have COVID-19 or are not suspected of having COVID-19. Current events surrounding the COVID-19 pandemic are challenging and all public health bodies are placing the safety of patients, staff and communities first in all decisions. This is an evolving situation. This advice is based on current information, it is additional to the advice of the NPHET, the HSE and the DoH, and will be updated as necessary. The NCCP acknowledges

2020 Health Service Executive (Ireland) - Clinical Guidelines

2. Infection prevention and control for novel coronavirus (COVID-19): interim guidance for acute healthcare settings

Infection prevention and control for novel coronavirus (COVID-19): interim guidance for acute healthcare settings Infection prevention and control for coronavirus disease (COVID-19): Interim guidance for acute healthcare settings - Canada.ca Language selection Search Search Canada.ca Search Menu Main Menu You are here: Infection prevention and control for coronavirus disease (COVID-19): Interim guidance for acute healthcare settings Table of Contents Introduction The Public Health Agency (...) and Control Measures at a Glance In the absence of effective drugs or vaccines, Infection Prevention and Control (IPC) strategies to prevent or limit transmission of COVID-19 in healthcare facilities include: Prompt identification of individuals with ; Institution of appropriate infection prevention and control (IPC) measures (e.g., contact and droplet precautions, patient isolation); and Determination of the etiologic diagnosis. Early Recognition and Source Control To facilitate early recognition

2020 CPG Infobase

3. Novel coronavirus (COVID-19) guidance for acute care

Novel coronavirus (COVID-19) guidance for acute care 1 | Pa g e Ministry of Health Novel Coronavirus (COVID-19) Guidance for Acute Care Version 2 – February 1 1, 2020 This guidance document provides basic information only. It is not intended to take the place of medical advice, communicable diseases surveillance protocols, diagnosis or treatment. What you need to know Acute care settings should: 1. Undertake active screening (asking questions) and passive screening (signage) of patients (...) to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV), Severe Acute Respiratory Syndrome (SARS-CoV), and COVID-19. A novel coronavirus is a new strain that has not been previously identified in humans. Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Detailed investigations found that SARS-CoV was transmitted from civet cats to humans and MERS-CoV from dromedary camels to humans, likely through bat reservoirs. Several known coronaviruses

2020 CPG Infobase

4. Interim guidance: public health management of cases and contacts associated with novel coronavirus (COVID-19) in the community

for longer in the immunocompromised and pediatric populations. Two negative swabs, collected at least 24 hours apart, AND resolution of acute symptoms are required to rule out communicability and discontinue isolation DIAGNOSTIC TESTING PCR developed at BCCDC PHL Up to date lab testing guidelines can be found on the BCCDC Health Professionals page: http://www.bccdc.ca/health-professionals/clinical-resources/novel-coronavirus-(covid-19) SURVEILLANCE AND REPORTING Case definitions have been developed (...) Interim guidance: public health management of cases and contacts associated with novel coronavirus (COVID-19) in the community Interim Guidance: Public Health Management of cases and contacts associated with novel coronavirus (COVID-19) in the community March 10, 2020 CONTEXT The British Columbia Centre for Disease Control (BCCDC) has adapted the interim guidance from the Public Health Agency of Canada (PHAC) for Regional Health Authorities (RHA) for public health management of human illness

2020 CPG Infobase

5. Novel coronavirus (COVID-19) Guidance for Primary Care Management of patients presenting to primary care

Novel coronavirus (COVID-19) Guidance for Primary Care Management of patients presenting to primary care Health Protection Scotland This document is uncontrolled when printed. Before use check the HPS COVID-19 page to verify this is the current version Novel coronavirus (COVID-19) Guidance for Primary Care Management of patients presenting to primary care Version 10.4 Publication date 27 March 2020 Health Protection Scotland 1 Version History Version Date Summary of changes V1.0 23/01/20 First (...) equipment 12 11.5. Carpeted flooring and soft furnishings 12 11.6. On leaving the room 13 11.7. Cleaning of communal areas 13 11.8. Attending deaths 13 12. Further information 13 Appendix 1: Contact details for local Health Protection Teams 14 Health Protection Scotland 4 Appendix 2: Putting on and removing Personal Protective Equipment (PPE) 15 Instructional video 16 Health Protection Scotland 5 1. Introduction Novel coronavirus (COVID-19) is a new is a new strain of coronavirus first identified

2020 Covid-19 Ad hoc guidelines

6. Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death - part 2

season, flu was not very prevalent due to the unusually warm winter. However, a case has been confirmed in which a medical doctor who conducted a rapid testing for a patient suspected influenza was infected with a novel coronavirus (SARS-CoV-2 or COVID-19 virus), because the patient was found infected with SARS-CV-2 later. Therefore, the Japan Medical Association recommended member doctors against testing even in case with suspected flu and recommended diagnosis based on the clinical symptoms [8 (...) Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death - part 2 MED CHECK April 2020/ Vol.6 No.17 · Page 17 C N o 17 M ED HECK 2 0 2 0 Editorial Sin of Being Deceived Urgent Recommendations Five Don'ts to Prevent COVID-19 and Death (Part 2) Five Do's to Prevent COVID-19 and Death Editorial Sin of Being Deceived Urgent Recommendations Five Don’ts to prevent COVID-19 and death (Part 2) 3. Don't use Tamiflu and Xofluza 4. Avoid ACE2 enhancers and (hidden) immunosuppressants 5

2020 Med Check - The Informed Prescriber

7. NCCP guidance for Medical Professionals for testing COVID-19 in asymptomatic patients undergoing elective cancer surgery in response to the current novel coronavirus pandemic

NCCP guidance for Medical Professionals for testing COVID-19 in asymptomatic patients undergoing elective cancer surgery in response to the current novel coronavirus pandemic Version: 2.00 Department: NCCP COVID-19 Surgical testing group Update date: 04/06/2020 Code: SO_COVID19_3 Revision date: 1 NCCP guidance for Medical Professionals for testing COVID- 19 in asymptomatic patients undergoing elective cancer surgery in response to the current novel coronavirus pandemic This document relates (...) ://www.gov.ie/en/campaigns/c36c85-covid-19- coronavirus/ ? Ireland’s National Action Plan in response to COVID-19 (Coronavirus) - https://www.gov.ie/en/campaigns/c36c85-covid-19-coronavirus/ Version: 2.00 Department: NCCP COVID-19 Surgical testing group Update date: 04/06/2020 Code: SO_COVID19_3 Revision date: 2 2 Purpose The purpose of this guidance document is to provide guidance for testing COVID-19 in asymptomatic patients undergoing elective cancer surgery in response to the current novel coronavirus

2020 Health Service Executive (Ireland) - Clinical Guidelines

8. Lung cancer: NCCP advice for medical professionals on the management of patients undergoing Lung Cancer Radiotherapy in response to the current novel coronavirus (COVID-19) pandemic

Lung cancer: NCCP advice for medical professionals on the management of patients undergoing Lung Cancer Radiotherapy in response to the current novel coronavirus (COVID-19) pandemic Version: 1 Department: NCCP Radiation Oncology Working Group Update date: 05/06/2020 Code: RO_COVID19_12 1 NCCP advice for medical professionals on the management of patients undergoing lung cancer radiotherapy in response to the current novel coronavirus COVID 19 pandemic This document relates to patients who do (...) not have COVID-19 or are not suspected of having COVID-19. Current events surrounding the COVID-19 pandemic are challenging and all public health bodies are placing the safety of patients, staff and communities first in all decisions. This is an evolving situation. This advice is based on current information, it is additional to the advice of the NPHET, the HSE and the DoH, and will be updated as necessary. The NCCP acknowledges that each hospital is working under individual constraints, including

2020 Health Service Executive (Ireland) - Clinical Guidelines

9. NCCP advice for Medical Professionals on the management of patients undergoing Systemic Anti-Cancer Therapy (chemotherapy) in response to the current novel coronavirus (COVID-19) outbreak

NCCP advice for Medical Professionals on the management of patients undergoing Systemic Anti-Cancer Therapy (chemotherapy) in response to the current novel coronavirus (COVID-19) outbreak 1 NCCP advice for Medical Professionals on the management of patients undergoing SACT Changes and additions from the last version are highlighted in yellow Version: 12.0 Department: NCCP Update date: 15/06/2020 CD19-013-003 Revision date: NCCP Systemic Therapy Programme NCCP advice for Medical Professionals (...) on the management of patients undergoing Systemic Anti-Cancer Therapy (chemotherapy) in response to the current novel coronavirus (COVID-19) pandemic 1 Overview Current events surrounding the COVID 19 pandemic are challenging and all public health bodies are placing the safety of patients, staff and communities first in all decisions. This is an evolving situation. This advice is based on current information, it is additional to the advice of the NPHET, the HSE and the DoH, and will be updated as necessary

2020 Health Service Executive (Ireland) - Clinical Guidelines

10. NCCP guidance for Medical Professionals on the management of patients with Prostate Cancer in response to the current novel coronavirus (COVID-19) outbreak

NCCP guidance for Medical Professionals on the management of patients with Prostate Cancer in response to the current novel coronavirus (COVID-19) outbreak Version: 4 Department: Prostate Guideline Development Group/Leads Group Update date: 11/06/2020 Revision date: Page 1 of 4 NCCP guidance for Medical Professionals on the management of patients with Prostate Cancer in response to the current novel coronavirus (COVID-19) pandemic This document relates to patients who do not have COVID-19 (...) - coronavirus/ ? Ireland’s National Action Plan in response to COVID-19 (Coronavirus) - https://www.gov.ie/en/campaigns/c36c85-covid-19-coronavirus/ Version: 4 Department: Prostate Guideline Development Group/Leads Group Update date: 11/06/2020 Revision date: Page 2 of 4 2 Purpose The purpose of this guidance document is to provide guidance to medical professionals on the management of patients referred to urology clinics, patients awaiting biopsy tests and patients diagnosed with prostate cancer during

2020 Health Service Executive (Ireland) - Clinical Guidelines

11. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)

A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) POSITION ARTICLE AND GUIDELINE Open Access A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) Ying-Hui Jin 1 , Lin Cai 2 , Zhen-Shun Cheng 3 , Hong Cheng 4 , Tong Deng 1,5 , Yi-Pin Fan 6,7 , Cheng Fang 1 , Di Huang 1 , Lu-Qi Huang 6,7 , Qiao Huang 1 , Yong Han 2 ,BoHu 8 , Fen Hu 8 (...) 1,18* , Yong-Yan Wang 6,7* , Xing-Huan Wang 1,2* , for the Zhongnan Hospital of Wuhan University Novel Coronavirus Management and Research Team, Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM) Abstract In December 2019, a new type viral pneumonia cases occurred in Wuhan, Hubei Province; and then named “2019 novel coronavirus (2019-nCoV)” by the World Health Organization (WHO) on 12 January 2020. For it is a never been

2020 Covid-19 Ad hoc guidelines

12. Clinical practice guidelines and experts’ consensuses of traditional Chinese herbal medicine for novel coronavirus (COVID-19): protocol of a systematic review Full Text available with Trip Pro

from epidemic into pandemic. As the initial outbreak area, China has taken multiple active measures to deal with the epidemic. Updated versions of diagnosis and treatment guideline for novel coronavirus (COVID-19) patients have been issued, and traditional Chinese herbal medicine has been recommended as a treatment. The objective of this study will be to summarize the recommendations in current clinical practice guidelines about the use of traditional Chinese herbal medicine for COVID-19 patients (...) Clinical practice guidelines and experts’ consensuses of traditional Chinese herbal medicine for novel coronavirus (COVID-19): protocol of a systematic review Clinical practice guidelines and experts’ consensuses of traditional Chinese herbal medicine for novel coronavirus (COVID-19): protocol of a systematic review | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed

2020 Research Square

13. Clinical Practice Guidelines of Traditional Chinese Herbal Medicine for Novel Coronavirus (Covid-19): Protocol of a Systematic Review Full Text available with Trip Pro

: This work is licensed under a CC BY 4.0 License. View the published version . Abstract Background: The World Health Organization declared on 11 March 2020 that thespread of the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) had escalated from epidemic into pandemic. As the initial outbreak area, China has taken multiple active measures to deal with the epidemic. Updated versions of diagnosis and treatment guideline for novel coronavirus (COVID-19)patients have been issued, and traditional (...) . Updated versions of diagnosis and treatment guideline for novel coronavirus (COVID-19)patients have been issued, and traditional Chinese herbal medicine has been recommended as a treatment. Methods: In this systematic review, we will search for guidelines, expert consensuses and policy documents published since December 2019 in electronic databases and on websites of governments or organizations. Eligible documents will be independently selected, and relevant data will be independently extracted

2020 Research Square

14. Risk factors associated with fatal outcomes of novel coronavirus infection pneumonia (COVID-19): A systematic review and meta-analysis Full Text available with Trip Pro

: ... Subject Areas Learn more about our company. This is a preprint. It has not completed peer review. Systematic Review Risk factors associated with fatal outcomes of novel coronavirus infection pneumonia (COVID-19): A systematic review and meta-analysis Can Chen, Danying Yan, Yuqing Zhou, Guo Tian, Jie Wu, Xiaoxiao Liu, Chenyang Huang, Xiaofang Fu, Cheng Ding, Lei Lan, Chencheng Wang, Wei Wu, Robert Hecht, Changtai Zhu, Lanjuan Li, Shigui Yang Can Chen State Key Laboratory for Diagnosis and Treatment (...) Risk factors associated with fatal outcomes of novel coronavirus infection pneumonia (COVID-19): A systematic review and meta-analysis Risk factors associated with fatal outcomes of novel coronavirus infection pneumonia (COVID-19): A systematic review and meta-analysis | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting

2020 Research Square

15. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Full Text available with Trip Pro

. We aim to describe the time kinetics of various antibodies produced against the 2019 novel coronavirus (SARS-CoV-2) and evaluate the potential of antibody testing to diagnose COVID-19.The host humoral response against SARS-CoV-2, including IgA, IgM, and IgG response, was examined by using an ELISA-based assay on the recombinant viral nucleocapsid protein. 208 plasma samples were collected from 82 confirmed and 58 probable cases (qPCR negative but with typical manifestation). The diagnostic value (...) Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). The emergence of coronavirus disease 2019 (COVID-19) is a major healthcare threat. The current method of detection involves a quantitative polymerase chain reaction (qPCR)-based technique, which identifies the viral nucleic acids when present in sufficient quantity. False-negative results can be achieved and failure to quarantine the infected patient would be a major setback in containing the viral transmission

2020 Clinical Infectious Diseases

16. Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review Full Text available with Trip Pro

Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review | SpringerLink Search Search SpringerLink Search Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review Role (...) of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review , , , , , , , , , , , , , , & volume 44 , Article number: 122 ( 2020 ) 4225 Accesses 19 Citations 6 Altmetric Abstract Coronaviruses (CoVs) are a large family of viruses that are common in many animal species, including camels, cattle, cats and bats. Animal CoVs, such as Middle East respiratory syndrome-CoV, severe acute respiratory syndrome (SARS)-CoV, and the new

2020 Journal of medical systems

17. Prospective study comparing deep-throat saliva with other respiratory tract specimens in the diagnosis of novel coronavirus disease (COVID-19). Full Text available with Trip Pro

Prospective study comparing deep-throat saliva with other respiratory tract specimens in the diagnosis of novel coronavirus disease (COVID-19). Self-collected specimens has been advocated to avoid infectious exposure to healthcare workers. Self-induced sputum in those with a productive cough, and saliva in those without a productive cough have been proposed, but sensitivity remains uncertain.We performed a prospective study in two regional hospitals in Hong Kong.We prospectively examined 563

2020 Journal of Infectious Diseases

18. Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts

Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts 1 Home care for patients with COVID-19 presenting with mild symptoms and management of their contacts Interim guidance 17 March 2020 Background WHO has developed this interim guidance to meet the need for recommendations on safe home care for patients with suspected COVID-19 who present with mild symptoms a and on public health measures related to the management (...) of their contacts. This document was adapted from the interim guidance on Middle East respiratory syndrome coronavirus (MERS-CoV) infection that was published in June 2018 1 and is informed by evidence-based guidelines published by WHO, including Infection prevention and control of epidemic- and pandemic- prone acute respiratory diseases in health care, 2 and based on current information on COVID-19. This rapid advice has been updated with the latest information and is intended to guide public health

2020 WHO Coronavirus disease (COVID-19) Pandemic

19. Novel coronavirus (2019-nCoV): self-isolation for patients undergoing testing

for how patients should self-isolate while awaiting results of laboratory testing for SARS-CoV-2. Published 31 January 2020 Last updated 31 January 2020 — From: Documents HTML HTML HTML Details This guidance provides advice for individuals who are awaiting results from diagnostic testing for COVID-19 and do not require admission to hospital. COVID-19 was previously referred to as Wuhan novel coronavirus. There may be further information specific to each country in the United Kingdom, as this guidance (...) Novel coronavirus (2019-nCoV): self-isolation for patients undergoing testing COVID-19: self-isolation for patients undergoing testing - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search The UK has left the EU Guidance COVID-19: self-isolation for patients undergoing testing Guidance

2020 Public Health England

20. COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection. Full Text available with Trip Pro

COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection. Recent retrospective studies from Wuhan, China suggest Novel Coronavirus Disease 2019 (COVID-19) may be associated with a hypercoagulable state and increased risk for venous thromboembolism. The overlap in the signs and symptoms of COVID-19 associated Acute Respiratory Distress Syndrome (ARDS) and COVID-19 with concurrent pulmonary embolism creates a diagnostic challenge (...) for emergency medicine physicians in patients already at risk for renal impairment. However, identifying features atypical for COVID-19 alone may play a role in the judicious use of Computed Tomography Angiography among these patients. Hemoptysis is seen in roughly 13% of pulmonary embolism cases and infrequently reported among COVID-19 infections. Additionally, the presence of right heart strain on electrocardiography (EKG) is a well described clinical presentations of pulmonary embolism not reported

2020 American Journal of Emergency Medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>